Michele Skibsted, Vice President of Business Development
Michele Skibsted is a recognized expert in the application of new technology in hospital and health care settings. She has more than six years of experience in the successful implementation of mHealth and telehealth technologies and during her tenure at Entra Health Systems, Michele has overseen numerous provider implementations of the Entra’s MyGlucoHealth wireless glucose meter and MyHealthPoint clinical systems. She has worked closely with both patients and providers to streamline the implementation process and develop systems for successfully using mHealth technology.
Michele’s career also includes key positions in surgery. She was at the forefront of the laparoscopic surgical revolution while at U.S. Surgical Corporation, now Covidien (NYSE: COV). Her extensive training at U.S. Surgical included personally performing over 300 laparoscopic procedures in the lab in preparation for training surgeons how to perform the new laparoscopic techniques.
While at Stryker Corporation (NYSE: SYK), Michele trained both ENT and Neurosurgeons in the effective use of specialized navigation technology. Navigation technology is used to overlay imagery of a tumor with a tracking image of the surgeon’s instrument in the brain.
Skibsted is a graduate of the University of Alberta.